OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Neurology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
SEEG in 2025: progress and pending challenges in stereotaxy methods, biomarkers and radiofrequency thermocoagulation	63
Autoimmune movement disorders with neuronal antibodies – an update	57
Learning from the comorbidities of epilepsy	55
Update on genetics of amyotrophic lateral sclerosis	52
Headache in infections	51
How can you manage an indomethacin-responsive headache in someone who cannot take indomethacin?	47
Ultra-high dose methylcobalamin and other emerging therapies for amyotrophic lateral sclerosis	41
Impulse control disorders and related behaviors in Parkinson's disease: risk factors, clinical and genetic aspects, and management	38
Rescue therapies in epilepsy	37
Editorial introductions	36
Advanced neuroimaging techniques in epilepsy	36
Editorial introductions	32
Editorial: Clinical epileptology entering the era of personalized medicine	31
Insights into a personalized management of blood pressure in acute stroke	27
Cancer stem cells in gliomas: evolving concepts and therapeutic implications	25
Primary central nervous system vasculitis and headache: Ten themes	24
The recent surge of functional movement disorders: social distress or greater awareness?	23
Update on neuroimaging in brain tumours	23
MRI and laboratory monitoring of disease-modifying therapy efficacy and risks	23
Abnormal energy metabolism in ALS: a key player?	22
Sudden unexpected death in epilepsy	22
Guillain-Barré syndrome in an era of global infections and 21st century vaccination	21
Management of neuropsychiatric symptoms in dementia	20
Old muscle, new tricks: a clinician perspective on sarcopenia and where to next	20
Recent advances in our understanding of genetic rhabdomyolysis	20

New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome	19
Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis	19
Promises and pitfalls of imaging-based biomarkers in motor neuron diseases	19
Fluid phase biomarkers in multiple sclerosis	19
Update on neuroimaging in Alzheimer's disease	18
Deciphering the contributions of neuroinflammation to neurodegeneration: lessons from antibody-mediated encephalitis and coronavirus disease 2019	18
Traumatic brachial plexus injury: diagnosis and treatment	18
Endogenous clues promoting remyelination in multiple sclerosis	18
Coronavirus disease 2019 infection and cerebrovascular diseases: an update on the pathophysiology and management	17
Neuropathogenesis of acute coronavirus disease 2019	17
Editorial: Neuromuscular diseases: differential diagnosis and targeted treatment	17
Editorial: Current opinions in neurology editorial	17
PET-based brain molecular connectivity in neurodegenerative disease	17
Neuropathology and epilepsy surgery	17
Neuromuscular complications of cancer therapy	17
Visually induced dizziness	16
The state of art on the use of patient reported outcomes in migraine	16
Hypoventilation syndrome in neuromuscular disorders	16
Editorial: Degenerative and cognitive diseases	16
Editorial introductions	16
Medical technologies, telemedicine and artificial intelligence for neurotrauma and neurorehabilitation	15
An update on the role of focused ultrasound in neuro-oncology	15
Neuropathology and neuroanatomy of TDP-43 amyotrophic lateral sclerosis	15
Current opinion: Racial and ethnic health disparities in multiple sclerosis: considering the social determinants of health	15
Diagnosing viral encephalitis and emerging concepts	14
Reproducibility and replicability in neuroimaging data analysis	14
Chemotherapy and targeted therapies for meningiomas: what is the evidence?	14
Update on management of cerebral venous thrombosis	13
Socioeconomic disparities in epilepsy care	13
The genetics of amyotrophic lateral sclerosis	13
Addressing vaccine-preventable encephalitis in vulnerable populations: Erratum	13
Cerebral amyloid angiopathy: one single entity?	13
Recent insights in striated muscle laminopathies	13
The optic nerve in spaceflight: novel concepts in the pathogenesis of optic disc edema in microgravity	13
Neuroinflammation in amyotrophic lateral sclerosis: pathogenic insights and therapeutic implications	13
Current trend in air pollution exposure and stroke	13
Understanding multiple sclerosis as a disease spectrum: above and below the clinical threshold	13
An update on Becker muscular dystrophy	13
Intravenous thrombolysis for acute ischemic stroke: why not?	13
Pregnancy and reproductive health in women with multiple sclerosis: an update	12
Monitoring multiple sclerosis: digital and fluid phase biomarkers	12
Central vestibular networking for sensorimotor control, cognition, and emotion	12
Congenital myasthenic syndromes: increasingly complex	12
Pharmacological treatment for older adults with epilepsy and comorbid neurodegenerative disorders	12
Cannabinoids in headache: helpful or harmful?	12
Contraception, fecundity, and pregnancy in women with epilepsy: an update on recent literature	11
Noninvasive neuromodulation and rehabilitation to promote functional restoration in persons with spinal cord injury	11
Hereditary motor neuropathies	11
Diagnostic criteria for amyotrophic lateral sclerosis	11
Therapeutic developments for valosin-containing protein mediated multisystem proteinopathy	11

Central nervous system adverse events of immune checkpoint inhibitors	11
A patient with neuropathy and ataxia: what do I have to consider?	11
What visuospatial perception has taught us about the pathophysiology of vestibular migraine	10
Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies	10
T cell dysfunction in glioblastoma: a barrier and an opportunity for the development of successful immunotherapies	10
Imaging cortical lesions in multiple sclerosis	10
Editorial: Making the invisible visible: updates on vestibular neurology	10
Noninvasive brain stimulation to improve motor outcomes after stroke	10
Triggers of migraine: where do we stand?	10
Clinical and neuroimaging features of the progressive supranuclear palsy- corticobasal degeneration continuum	10
The atypical faces of optic neuritis: neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease	9
Recent advances in portable, low-field magnetic resonance imaging in cerebrovascular disease	9
Neurology education in the era of artificial intelligence	9
Gene therapies for CMT neuropathies: from the bench to the clinic	9
Precision medicine in secondary prevention of ischemic stroke: how may blood-based biomarkers help in clinical routine? An expert opinion	9
Editorial introductions	9
Recent insights into haematology and peripheral nerve disease	9
Visual snow syndrome: recent advances in understanding the pathophysiology and potential treatment approaches	9
Historical development and contemporary use of neuromodulation in human spinal cord injury	8
Noninvasive methods to monitor intracranial pressure	8
Editorial introductions	8
Microglia in multiple sclerosis – pathogenesis and imaging	8
From basic mechanisms to therapeutic perspectives in cluster headache	8
Autoimmune neuromyotonia	8
The 2021 WHO classification of central nervous system tumors: what neurologists need to know	8
Neuroscience and oncology: state-of-the-art and new perspectives	8
Advances in functional and structural imaging of the brainstem: implications for disease	8
Myoclonus: an update	8
Fragile X-associated tremor/ataxia syndrome: pathophysiology and management	8
Prevention of epileptogenesis – are we there yet?	8
Editorial introductions	8
Neurocognitive and psychiatric post-coronavirus disease 2019 conditions: pathogenic insights of brain dysfunction following severe acute respiratory syndrome coronavirus 2 infection	8
Sleep and circadian rhythm dysfunctions in movement disorders beyond Parkinson's disease and atypical parkinsonisms	8
The role of caffeine in headache disorders	8
New knowledge on anti-IgLON5 disease	8